NCT00464893 2013-12-04
Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection
Neovii Biotech
Phase 2 Completed
Clinical Trials
3 trialsNCT00836654 2009-02-05
Study in EpCAM Positive Patients With Symptomatic Malignant Ascites Using Removab Versus an Untreated Control Group
Neovii Biotech
Phase 2/3 Completed
NCT00352833 2007-10-26
Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma
Neovii Biotech
Phase 2 Completed